JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on March 10, 2005; DOI: 10.1124/jpet.105.083428


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.083428v1
313/3/962    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Banan, A.
Right arrow Articles by Keshavarzian, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Banan, A.
Right arrow Articles by Keshavarzian, A.


Received for publication January 13, 2005.
Revised March 2, 2005.
Accepted for publication March 2, 2005.

Theta ({Theta}) Isoform of PKC Alters Barrier Function in Intestinal Epithelium through Modulation of Distinct Claudin Isotypes: A Novel Mechanism for Regulation of Permeability

A. Banan 1*, L.J. Zhang 1, M. Shaikh 1, J. Z. Fields 1, S. Choudhary 1, C. B. Forsyth 1, Ashkan Farhadi 1, A. Keshavarzian 1

1 Rush University Medical Center

* Address correspondence to: E-mail: ali_banan{at}rush.edu

Abstract

Using monolayers of intestinal Caco-2 cells, we discovered that the theta isoform of PKC, a member of the "novel" subfamily of PKC isoforms, is required for monolayer barrier function. However, the mechanisms underlying this novel effect remains largely unknown. Here, we sought to determine whether the mechanism by which PKC-{Theta} disrupts monolayer permeability and dynamics in intestinal epithelium involves PKC-{Theta} induced alterations in claudin isotypes. We utilized cell clones that we recently developed, clones which were transfected with varying levels of plasmid to either stably suppress endogenous PKC-{Theta} activity (anti-sense, dominant negative constructs) or to ectopically express PKC-{Theta} activity (sense constructs). We then determined barrier function; claudin isotype integrity; PKC-{Theta} subcellular activity; claudin isotype subcellular pools; and claudin phosphorylation. Anti-sense transfection to under-express the PKC-{Theta} led to monolayer instability as shown by reduced: [1] endogenous PKC-{Theta} activity, [2] claudin isotypes in the membrane & cytoskeletal pools (decreased claud-1, claud-4 assembly), [3] claudin isotypes phosphorylation (decreased phospho-serine, phospho-threonine), [4] architectural stability of the claudin-1 & claudin-4 rings, and [5] monolayer barrier function. In these anti-sense clones PKC-{Theta} activity was also substantially reduced in the membrane & cytoskeletal cell fractions. In wild type (WT) cells, PKC-{Theta} (82 kDa) was both constitutively active and co-associated with claudin-1 (22 kDa) and claudin-4 (25 kDa), forming endogenous PKC-{Theta}/claudin complexes. In a 2nd series of studies, dominant negative inhibition of the endogenous PKC-{Theta} caused similar destabilizing effects on monolayer barrier dynamics, including claudin-1 & -4 hypo-phosphorylation, disassembly, and architectural instability as well as monolayer disruption. In a 3rd series of studies, sense over-expression of the PKC-{Theta} caused not only a mostly cytosolic distribution of this isoform (i.e., <12% in the membrane + cytoskeletal fractions, indicating PKC-{Theta} inactivity), but also led to disruption of claudins assembly and barrier function of the monolayer. Conclusions: PKC-{Theta} activity is required for normal claudin assembly and the integrity of the intestinal epithelial barrier. These effects of PKC-{Theta} are mediated at the molecular level by changes in phosphorylation, membrane assembly, and/or organization of the subunit components of two barrier function proteins: claudin-1 and claudin-4 isotypes. The ability of PKC-{Theta} to alter the dynamics of permeability protein claudins is a new function not previously ascribed to the "novel" subfamily of PKC isoforms.


Key words: Cytoskeleton, Epithelial Barrier Function, GI, IBD, Inflammation, PKC isoform


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
J.-i. Koizumi, T. Kojima, N. Ogasawara, R. Kamekura, M. Kurose, M. Go, A. Harimaya, M. Murata, M. Osanai, H. Chiba, et al.
Protein Kinase C Enhances Tight Junction Barrier Function of Human Nasal Epithelial Cells in Primary Culture by Transcriptional Regulation
Mol. Pharmacol., August 1, 2008; 74(2): 432 - 442.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
N. Thongon, L.-i. Nakkrasae, J. Thongbunchoo, N. Krishnamra, and N. Charoenphandhu
Prolactin stimulates transepithelial calcium transport and modulates paracellular permselectivity in Caco-2 monolayer: mediation by PKC and ROCK pathways
Am J Physiol Cell Physiol, May 1, 2008; 294(5): C1158 - C1168.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. B. Forsyth, A. Banan, A. Farhadi, J. Z. Fields, Y. Tang, M. Shaikh, L. J. Zhang, P. A. Engen, and A. Keshavarzian
Regulation of Oxidant-Induced Intestinal Permeability by Metalloprotease-Dependent Epidermal Growth Factor Receptor Signaling
J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 84 - 97.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. M. McKay, J. L. Watson, A. Wang, J. Caldwell, D. Prescott, P. M. J. Ceponis, V. Di Leo, and J. Lu
Phosphatidylinositol 3'-Kinase Is a Critical Mediator of Interferon-{gamma}-Induced Increases in Enteric Epithelial Permeability
J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1013 - 1022.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Lioni, P. Brafford, C. Andl, A. Rustgi, W. El-Deiry, M. Herlyn, and K. S.M. Smalley
Dysregulation of Claudin-7 Leads to Loss of E-Cadherin Expression and the Increased Invasion of Esophageal Squamous Cell Carcinoma Cells
Am. J. Pathol., February 1, 2007; 170(2): 709 - 721.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.